Valuation (59%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 21.48 | 3.77 |
| PEG Ratio (TTM) | -0.40 | -2.86 |
| P/S Ratio (TTM) | 0.88 | 1.11 |
| P/B Ratio (TTM) | 2.78 | 2.77 |
| P/FCF Ratio (TTM) | 35.53 | 11.54 |
| Price to 5YR AVG Earnings Ratio | 16.99 | 20.09 |
| Price to 5YR AVG FCF Ratio | 51.88 | 9.28 |
Profitability (50%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 8.79% | 3.33% |
| ROE (TTM) | 13.27% | 15.64% |
| Net Profit Margin (TTM) | 4.10% | 3.21% |
| ROIC 5YR AVG | 22.21% | 14.60% |
Growth (85%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 3.28% | 168.56% | 101.80% |
| Revenue | -1.12% | 38.12% | 27.59% |
| Net Income | 2.70% | 169.93% | 102.30% |
| Cash Flow | 169.72% | 355.53% | 256.42% |
Health (79%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 5.88 | 3.26 |
| Quick Ratio (TTM) | 2.72 | 2.56 |
| D/E Ratio (TTM) | 0.32 | 1.64 |
| Interest Coverage (TTM) | 16.89 | 26.25 |
| Piotroski F-Score | 6 | 6 |
| Altman Z-Score | 6.96 | 2.35 |
| LTL to 5YR AVG FCF | 5.09 | 4.92 |
| Shares Outstanding Growth 5YR AVG | -0.15% | -4.03% |